• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Molecular Methods for Detecting Epstein-Barr Virus (Part III): EBV Viral Load by Competitive Polymerase Chain Reaction

        互联网

        598
        Epstein-Barr virus (EBV) viral load testing is rapidly gaining acceptance in the diagnosis and monitoring of patients with EBV-related neoplasia, including transplant recipients, autoimmune deficiency syndrome (AIDS) patients with brain lymphoma, and patients with nasopharyngeal carcinoma. In transplant recipients, several studies have shown that EBV viral load in blood is a useful marker of EBV-driven posttransplant lymphoproliferative disease (PTLD), both in terms of predicting disease and in monitoring efficacy of therapy (1 4 ). In AIDS patients, high EBV viral load in cerebrospinal fluid (CSF) is so characteristic of brain lymphoma that the assay has been touted as sufficient for making that diagnosis without the need for brain biopsy, assuming that there is also clinical and radiographic support for the diagnosis (5 ). In nasopharyngeal carcinoma patients, a recent study showed that plasma EBV viral load is nearly always elevated, and the degree of elevation is higher in those with distant metastases (6 ). Additional studies are needed to more completely define the utility of EBV viral load measurement in monitoring residual disease following therapy, and to evaluate clinical utility in other EB V-associated diseases.
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序